3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
12
Radiation Injuries
3
Glioma
3
Glioblastoma
2
Cognitive Dysfunction
2
Astrocytoma
2
Stroke
1
Pituitary Neoplasms
1
Parkinson Disease
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Infratentorial Neoplasms
1
Fatigue
1
Interventions
Proton Therapy
2
pegvisomant
1
lutetium Lu 177 dotatate
1
entinostat
1
Temozolomide
1
Surveys and Questionnaires
1
Rosiglitazone
1
Radiation Dose Hypofractionation
1
Protons
1
Prednisone
1
Photochemotherapy
1
Octreotide
1
Neuropsychological Tests
1
Microarray Analysis
1
Hydrocortisone
1
Dihematoporphyrin Ether
1
Dexamethasone
1
DNA Methylation
1
Clinical Laboratory Techniques
1
Calcium Dobesilate
1
Cabergoline
1
Blood Specimen Collection
1
Aminolevulinic Acid
1
90Y-octreotide, DOTA-Tyr(3)-
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pituitary Neoplasms
×
Neuropsychological Tests
×
CNS
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled